Newsletter | October 21, 2026

10.21.26 -- Packaging And Labeling Support For A Global Cell Therapy Program

Welcome to the Clinical Supply Leader newsletter, delivering weekly updates on the latest developments in clinical trial supply and logistics. Based on your professional interests, we believe you’ll find it useful for pinpointing inefficiencies in your supply chain, staying up to date on regulatory changes, and identifying supplier partners. 
If not, you can unsubscribe at any time.

FEATURED EDITORIAL

Can Site Enrollment Data Improve Clinical Trial Forecasts?

Site enrollment data can sharpen clinical trial supply forecasts, helping teams adjust inventory, resupply, and manufacturing decisions before demand shifts become costly.

How New Models Could Improve Trial Enrollment Forecasts

New statistical and machine learning models could make clinical trial enrollment forecasts more adaptive, helping teams account for uncertainty and changing site performance.

Root Causes, Part 5: The Structural Changes Clinical Supply Needs

This fifth and final installment of our Root Causes video series explores the structural changes needed to improve clinical trial execution and clinical supply outcomes.

INDUSTRY INSIGHTS

Packaging And Labeling Support For A Global Cell Therapy Program

Master complex cell therapy logistics with coordinated depots, purpose-built labeling, and temperature-controlled solutions that protect product integrity.

How Sandoz Cut Its Supplier Network By 34%: A Consolidation Playbook

Sandoz cut its finished dose form supplier network by 34% in two years. Get the six-step make-vs-buy framework and three-phase consolidation approach that made it possible.

SOLUTIONS

Understanding Options In Direct-To-Patient Clinical Supply

MORE GREAT EDITORIAL

The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution

Broken RTSM–EDC integrations keep clinical trials stalled with blocked randomizations, kit errors, and endless reconciliations. Here’s how to fix workflows before tech fails.

Primary Healthcare Disruption And Clinical Trial Supply Risk

Funding cuts are destabilizing primary healthcare systems and exposing hidden risks in clinical trial supply, from cold chain breakdowns to site readiness gaps.

Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?

Clinical supply data reveals where protocol assumptions break down. Could those lessons help improve protocol design and reduce avoidable amendments?